MARSHALL EDWARDS, INC.
Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics.
MARSHALL EDWARDS, INC.
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.marshalledwardsinc.com
Total Employee:
11+
Status:
Active
Contact:
858-792-6300
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apache Mobile Non Scaleable Content AdBlock Acceptable Ads Citrix NetScaler Confluence Networks Data Foundry
Similar Organizations
Effector Therapeutics
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Flexus Biosciences
Flexus is a privately-held biopharmaceutical company focused on the creation of novel anti-cancer therapeutics.
MEI Pharma
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
Official Site Inspections
http://www.marshalledwardsinc.com
Unable to get host informations!!!
More informations about "Marshall Edwards, Inc."
Marshall Edwards, Inc. - Crunchbase Company Profile & Funding
Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics.See details»
Marshall Edwards, Inc. - Drug pipelines, Patents, Clinical trials
Explore Marshall Edwards, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 3 literature, Drug:Triphendiol.See details»
Marshall Edwards Appoints New President and CEO
Apr 26, 2010 · Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics. These derive from a flavonoid technology …See details»
Marshall Edwards Announces Name Change to MEI Pharma …
SAN DIEGO, June 28, 2012 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer …See details»
Marshall Edwards, Inc. - Crunchbase
Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics.See details»
Marshall Edwards, Inc. Raises Approximately $14 Million In
Jul 12, 2006 · Marshall Edwards, Inc. is a US clinical development oncology company and is majority owned by Novogen Limited , an Australian biotechnology company specializing in the …See details»
Marshall Edwards Announces FDA Approval of Investigational New …
Aug 16, 2011 · Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego -based oncology company focused on the clinical development of novel anti-cancer therapeutics. The …See details»
Marshall Edwards, Inc. - Tech Stack, Apps, Patents & Trademarks
Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics.See details»
Marshall Edwards, Inc. Raises US$16.4 Million in Private ... - BioSpace
Aug 7, 2007 · WASHINGTON, and SYDNEY, Australia, Aug. 7 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. announced today that it entered into definitive agreements for an approximately …See details»
Marshall Edwards, Inc. Raises A Total Of Approximately $18
Jul 13, 2006 · Marshall Edwards, Inc. is a US clinical development oncology company and is majority owned by Novogen Limited , an Australian biotechnology company specializing in the …See details»
Marshall Edwards, Inc. Appoints Oncologist Christine White
SAN DIEGO, Aug. 10 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, …See details»
Marshall Edwards Inc., Announces Final Results From Halted Phase …
Jun 1, 2010 · Marshall Edwards, Inc. (NASDAQ: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that a final analysis of …See details»
MRSHL EDW : Marshall Edwards Announces Election of William …
SAN DIEGO, April 14, 2011 /PRNewswire/ -- Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, …See details»
Marshall Edwards Appoints Oncologist Christine White to Board of …
Aug 10, 2010 · /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics,...See details»
Working at Marshall Edwards - Glassdoor
See what employees say it's like to work at Marshall Edwards. Salaries, reviews, and more - all posted by employees working at Marshall Edwards.See details»
Marshall Edwards, Inc. (NVGN) Appoints New President and CEO
Apr 26, 2010 · Marshall Edwards, Inc. is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics. These derive from a flavonoid technology …See details»
Novogen and Marshall Edwards Sign Asset Purchase Agreement
Dec 21, 2010 · Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego -based oncology company focused on the clinical development of novel anti-cancer therapeutics. The …See details»
New Board Appointment at Marshall Edwards, Inc. | BioSpace
Mar 28, 2007 · WASHINGTON and SYDNEY, Australia, March 28 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. is pleased to announce the appointment of Mr. William Rueckert to its …See details»
What is Marshall Edwards? Company Culture, Mission, Values
See what employees say it's like to work at Marshall Edwards. Salaries, reviews, and more - all posted by employees working at Marshall Edwards.See details»
Marshall Edwards, Inc. Appoints New President and CEO
Apr 26, 2010 · SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - 04/26/10) - Marshall Edwards, Inc. (NASDAQ:MSHLD - News), an oncology company focused on the clinical …See details»